Kraus, Christoph <br/><br/>
Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment.  [electronic resource] 

 -  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology  05 2020 
 - 982-989 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1740-634X 
<br/><br/><label>Standard No.: </label>10.1038/s41386-020-0624-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antidepressive Agents--therapeutic use<br/>Brain--diagnostic imaging<br/>Brain Mapping<br/>Depression<br/>Depressive Disorder, Major--diagnostic imaging<br/>Humans<br/>Ketamine--therapeutic use<br/>Magnetic Resonance Imaging